Literature DB >> 11858856

A review of emergency foot-and-mouth disease (FMD) vaccines.

P V Barnett1, H Carabin.   

Abstract

The primary objectives of this paper are to describe emergency foot-and-mouth disease (FMD) vaccines and review literature on emergency vaccine efficacy to protect animals against (1) clinical signs and (2) infection (local virus replication). The reviewed experiments suggest that in cattle, sheep and pigs, the vaccine could be effective in preventing disease within 4-5 days post-vaccination. These studies also suggest that the risk of spreading infection decreases as the interval between vaccine and challenge increases and that vaccination could reduce the amount of virus excreted compared to non-vaccinated animals. We suggest areas of future research to improve our knowledge of emergency vaccines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11858856     DOI: 10.1016/s0264-410x(01)00503-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Agriculture emergencies: a primer for first responders.

Authors:  Johnnie L Gilpen; Hélène Carabin; James L Regens; Ray W Burden
Journal:  Biosecur Bioterror       Date:  2009-06

2.  Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.

Authors:  Weizao Chen; Mingqiu Liu; Ye Jiao; Weiyao Yan; Xuefeng Wei; Jiulian Chen; Liang Fei; Yang Liu; Xiaoping Zuo; Fugui Yang; Yonggan Lu; Zhaoxin Zheng
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine.

Authors:  Wei Cong; Hong Jin; Chengda Jiang; Weiyao Yan; Mingqiu Liu; Jiulian Chen; Xiaoping Zuo; Zhaoxin Zheng
Journal:  Vet Res       Date:  2010-01-13       Impact factor: 3.683

4.  RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice.

Authors:  Weizao Chen; Weiyao Yan; Qingyun Du; Liang Fei; Mingqiu Liu; Zheng Ni; Zutian Sheng; Zhaoxin Zheng
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Inhibition of EHMT2 Induces a Robust Antiviral Response Against Foot-and-Mouth Disease and Vesicular Stomatitis Virus Infections in Bovine Cells.

Authors:  Neetu Singh; Lisbeth Ramĩrez-Carvajal; Teresa de Los Santos; Michael C Golding; Charles R Long
Journal:  J Interferon Cytokine Res       Date:  2015-09-29       Impact factor: 2.607

6.  Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.

Authors:  T J D Knight-Jones; A N Bulut; S Gubbins; K D C Stärk; D U Pfeiffer; K J Sumption; D J Paton
Journal:  Vaccine       Date:  2014-12-17       Impact factor: 3.641

7.  Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection.

Authors:  Shengwei Hu; Jun Qiao; Qiang Fu; Chuangfu Chen; Wei Ni; Sai Wujiafu; Shiwei Ma; Hui Zhang; Jingliang Sheng; Pengyan Wang; Dawei Wang; Jiong Huang; Lijuan Cao; Hongsheng Ouyang
Journal:  Elife       Date:  2015-06-19       Impact factor: 8.140

Review 8.  Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review.

Authors:  Sarah J Cox; Paul V Barnett
Journal:  Vet Res       Date:  2008-12-02       Impact factor: 3.683

Review 9.  Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Authors:  Mohammed Habiela; Julian Seago; Eva Perez-Martin; Ryan Waters; Miriam Windsor; Francisco J Salguero; James Wood; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2014-07-07       Impact factor: 3.891

10.  Analysis of SAT type foot-and-mouth disease virus capsid proteins and the identification of putative amino acid residues affecting virus stability.

Authors:  Francois F Maree; Belinda Blignaut; Tjaart A P de Beer; Elizabeth Rieder
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.